AAPL313.96-3.35 (-1.06%) ▼|ABBV245.01-3.00 (-1.21%) ▼|ABT89.81-2.30 (-2.50%) ▼|ACN134.55-3.97 (-2.87%) ▼|ADBE222.12-8.49 (-3.68%) ▼|AMAT592.04+16.65 (+2.89%) ▲|AMD551.01+16.62 (+3.11%) ▲|AMGN357.41-3.04 (-0.84%) ▼|AMT167.07-2.43 (-1.43%) ▼|AMZN245.71-1.60 (-0.65%) ▼|AVGO389.54+5.49 (+1.43%) ▲|AXP359.06+4.63 (+1.31%) ▲|BA218.50+2.99 (+1.39%) ▲|BAC60.66+1.16 (+1.94%) ▲|BKNG174.81-0.99 (-0.56%) ▼|BLK1,033.79+2.23 (+0.22%) ▲|BMY58.31-1.03 (-1.74%) ▼|BNY154.28+3.01 (+1.99%) ▲|BRK-B496.64-0.22 (-0.04%) ▼|C143.50+2.79 (+1.98%) ▲|CAT944.29+12.82 (+1.38%) ▲|CL92.31-0.90 (-0.97%) ▼|CMCSA23.68-0.30 (-1.23%) ▼|COF207.40+4.38 (+2.16%) ▲|COP112.15-0.70 (-0.62%) ▼|COST925.69-0.74 (-0.08%) ▼|CRM165.86-5.36 (-3.13%) ▼|CSCO119.12-0.13 (-0.11%) ▼|CVS105.78-0.12 (-0.11%) ▼|CVX182.25+0.05 (+0.02%) ▲|DE590.64+5.00 (+0.85%) ▲|DHR199.15-1.02 (-0.51%) ▼|DIS95.38-0.62 (-0.65%) ▼|DUK127.16+0.30 (+0.24%) ▲|EMR135.42+0.04 (+0.03%) ▲|FDX312.07-1.67 (-0.53%) ▼|GD375.68+2.90 (+0.78%) ▲|GE355.28+1.86 (+0.53%) ▲|GEV1,072.14+29.54 (+2.83%) ▲|GILD130.85-0.55 (-0.42%) ▼|GM76.73+0.01 (+0.01%) ▲|GOOG351.53+0.86 (+0.25%) ▲|GOOGL354.05+1.54 (+0.44%) ▲|GS1,122.99+77.08 (+7.37%) ▲|HD337.39+0.28 (+0.08%) ▲|HON223.32+1.07 (+0.48%) ▲|IBM219.56-70.67 (-24.35%) ▼|INTC104.76+1.64 (+1.59%) ▲|INTU278.25-11.51 (-3.97%) ▼|ISRG390.00-17.12 (-4.21%) ▼|JNJ254.97-2.80 (-1.09%) ▼|JPM342.57+8.04 (+2.40%) ▲|KO84.31+0.06 (+0.07%) ▲|LIN530.10+6.04 (+1.15%) ▲|LLY1,152.05-29.82 (-2.52%) ▼|LMT521.70+1.02 (+0.20%) ▲|LOW208.78+1.08 (+0.52%) ▲|LRCX342.86+12.94 (+3.92%) ▲|MA542.88+5.18 (+0.96%) ▲|MCD271.59-1.03 (-0.38%) ▼|MDLZ59.03-0.83 (-1.39%) ▼|MDT80.25-3.32 (-3.98%) ▼|META657.05+0.32 (+0.05%) ▲|MMM157.11-0.59 (-0.37%) ▼|MO71.42-0.45 (-0.63%) ▼|MRK121.81-2.22 (-1.79%) ▼|MS230.85+9.76 (+4.41%) ▲|MSFT383.49-7.50 (-1.92%) ▼|MU960.70+23.70 (+2.53%) ▲|NEE89.20+0.82 (+0.93%) ▲|NFLX73.24-0.60 (-0.81%) ▼|NKE42.91-0.85 (-1.94%) ▼|NOW105.32-5.94 (-5.34%) ▼|NVDA204.46+0.93 (+0.46%) ▲|ORCL128.93-2.62 (-1.99%) ▼|PEP137.94-0.56 (-0.40%) ▼|PFE24.30-0.18 (-0.74%) ▼|PG146.66-1.71 (-1.15%) ▼|PLTR131.45+1.41 (+1.08%) ▲|PM180.38+0.19 (+0.11%) ▲|QCOM181.46-2.52 (-1.37%) ▼|RTX198.23+1.84 (+0.93%) ▲|SBUX107.21-0.13 (-0.12%) ▼|SCHW103.08+0.70 (+0.68%) ▲|SO96.87+0.40 (+0.41%) ▲|SPG220.13+0.64 (+0.29%) ▲|T21.45-0.11 (-0.49%) ▼|TMO532.25+3.74 (+0.71%) ▲|TMUS187.78-0.63 (-0.33%) ▼|TSLA398.68+3.92 (+0.99%) ▲|TXN302.10+3.53 (+1.18%) ▲|UBER73.30-0.96 (-1.29%) ▼|UNH431.37+2.28 (+0.53%) ▲|UNP289.07-0.06 (-0.02%) ▼|UPS111.53-1.37 (-1.21%) ▼|USB62.95+0.61 (+0.98%) ▲|V358.85+1.10 (+0.31%) ▲|VZ42.48-0.21 (-0.48%) ▼|WFC88.46+0.79 (+0.90%) ▲|WMT115.63+0.85 (+0.74%) ▲|XOM145.39+0.88 (+0.61%) ▲|AAPL313.96-3.35 (-1.06%) ▼|ABBV245.01-3.00 (-1.21%) ▼|ABT89.81-2.30 (-2.50%) ▼|ACN134.55-3.97 (-2.87%) ▼|ADBE222.12-8.49 (-3.68%) ▼|AMAT592.04+16.65 (+2.89%) ▲|AMD551.01+16.62 (+3.11%) ▲|AMGN357.41-3.04 (-0.84%) ▼|AMT167.07-2.43 (-1.43%) ▼|AMZN245.71-1.60 (-0.65%) ▼|AVGO389.54+5.49 (+1.43%) ▲|AXP359.06+4.63 (+1.31%) ▲|BA218.50+2.99 (+1.39%) ▲|BAC60.66+1.16 (+1.94%) ▲|BKNG174.81-0.99 (-0.56%) ▼|BLK1,033.79+2.23 (+0.22%) ▲|BMY58.31-1.03 (-1.74%) ▼|BNY154.28+3.01 (+1.99%) ▲|BRK-B496.64-0.22 (-0.04%) ▼|C143.50+2.79 (+1.98%) ▲|CAT944.29+12.82 (+1.38%) ▲|CL92.31-0.90 (-0.97%) ▼|CMCSA23.68-0.30 (-1.23%) ▼|COF207.40+4.38 (+2.16%) ▲|COP112.15-0.70 (-0.62%) ▼|COST925.69-0.74 (-0.08%) ▼|CRM165.86-5.36 (-3.13%) ▼|CSCO119.12-0.13 (-0.11%) ▼|CVS105.78-0.12 (-0.11%) ▼|CVX182.25+0.05 (+0.02%) ▲|DE590.64+5.00 (+0.85%) ▲|DHR199.15-1.02 (-0.51%) ▼|DIS95.38-0.62 (-0.65%) ▼|DUK127.16+0.30 (+0.24%) ▲|EMR135.42+0.04 (+0.03%) ▲|FDX312.07-1.67 (-0.53%) ▼|GD375.68+2.90 (+0.78%) ▲|GE355.28+1.86 (+0.53%) ▲|GEV1,072.14+29.54 (+2.83%) ▲|GILD130.85-0.55 (-0.42%) ▼|GM76.73+0.01 (+0.01%) ▲|GOOG351.53+0.86 (+0.25%) ▲|GOOGL354.05+1.54 (+0.44%) ▲|GS1,122.99+77.08 (+7.37%) ▲|HD337.39+0.28 (+0.08%) ▲|HON223.32+1.07 (+0.48%) ▲|IBM219.56-70.67 (-24.35%) ▼|INTC104.76+1.64 (+1.59%) ▲|INTU278.25-11.51 (-3.97%) ▼|ISRG390.00-17.12 (-4.21%) ▼|JNJ254.97-2.80 (-1.09%) ▼|JPM342.57+8.04 (+2.40%) ▲|KO84.31+0.06 (+0.07%) ▲|LIN530.10+6.04 (+1.15%) ▲|LLY1,152.05-29.82 (-2.52%) ▼|LMT521.70+1.02 (+0.20%) ▲|LOW208.78+1.08 (+0.52%) ▲|LRCX342.86+12.94 (+3.92%) ▲|MA542.88+5.18 (+0.96%) ▲|MCD271.59-1.03 (-0.38%) ▼|MDLZ59.03-0.83 (-1.39%) ▼|MDT80.25-3.32 (-3.98%) ▼|META657.05+0.32 (+0.05%) ▲|MMM157.11-0.59 (-0.37%) ▼|MO71.42-0.45 (-0.63%) ▼|MRK121.81-2.22 (-1.79%) ▼|MS230.85+9.76 (+4.41%) ▲|MSFT383.49-7.50 (-1.92%) ▼|MU960.70+23.70 (+2.53%) ▲|NEE89.20+0.82 (+0.93%) ▲|NFLX73.24-0.60 (-0.81%) ▼|NKE42.91-0.85 (-1.94%) ▼|NOW105.32-5.94 (-5.34%) ▼|NVDA204.46+0.93 (+0.46%) ▲|ORCL128.93-2.62 (-1.99%) ▼|PEP137.94-0.56 (-0.40%) ▼|PFE24.30-0.18 (-0.74%) ▼|PG146.66-1.71 (-1.15%) ▼|PLTR131.45+1.41 (+1.08%) ▲|PM180.38+0.19 (+0.11%) ▲|QCOM181.46-2.52 (-1.37%) ▼|RTX198.23+1.84 (+0.93%) ▲|SBUX107.21-0.13 (-0.12%) ▼|SCHW103.08+0.70 (+0.68%) ▲|SO96.87+0.40 (+0.41%) ▲|SPG220.13+0.64 (+0.29%) ▲|T21.45-0.11 (-0.49%) ▼|TMO532.25+3.74 (+0.71%) ▲|TMUS187.78-0.63 (-0.33%) ▼|TSLA398.68+3.92 (+0.99%) ▲|TXN302.10+3.53 (+1.18%) ▲|UBER73.30-0.96 (-1.29%) ▼|UNH431.37+2.28 (+0.53%) ▲|UNP289.07-0.06 (-0.02%) ▼|UPS111.53-1.37 (-1.21%) ▼|USB62.95+0.61 (+0.98%) ▲|V358.85+1.10 (+0.31%) ▲|VZ42.48-0.21 (-0.48%) ▼|WFC88.46+0.79 (+0.90%) ▲|WMT115.63+0.85 (+0.74%) ▲|XOM145.39+0.88 (+0.61%) ▲|
28.8 C
New York
Tuesday, July 14, 2026

Tag: press

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) (4174. TWO), and TegMine Therapeutics, Inc. (TegMine), a US Biopharma specialized in developing best-in-class antibodies targeting cancer glycans and glycoproteins, have entered into an ADC-related Master Services Agreement (MSA).

HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid

JAVENÉ, France, June 6, 2025 /PRNewswire/ -- On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President...

Palantir’s Playing Soldier — Don’t Buy the Hype

Palantir’s under fire again, and they're not dealing with it gracefully. Amid growing scrutiny, they’ve gone on the offensive—threatening journalists and booting critics from...

WEC Energy Group announces upsize and pricing of $775 million of 3.375% Convertible Senior Notes due 2028

MILWAUKEE, June 5, 2025 /PRNewswire/ -- WEC Energy Group, Inc. (NYSE: WEC) today announced the pricing of $775,000,000 in aggregate principal amount of its...

DFS Presents “Summer Beauty Carnival” at Hysan Place

Featuring Over 50 Global Beauty Brands with Privileges Up to 65% Off and Shopping Rewards Up to HK$3,000Rising Guitarist Dale Makes Special AppearanceWeekly Friday Flash Deals with...

SABLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Sable Offshore Corp. on Behalf of Sable Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sable Offshore Corp. (“Sable” or the “Company”) (NYSE:SOC) on behalf of Sable stockholders. Our investigation concerns whether Sable has violated the federal securities laws and/or engaged in other unlawful business practices.

Bitcoin Mining World Secures Exclusive Rights to Antminer S21 Pro Hashboard Schematics

BROOKFIELD, Wis., June 5, 2025 /PRNewswire/ -- Bitcoin Mining World (BMW), a leading educational platform for the Bitcoin mining community, has entered into an...

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

ZEISS CLARUS 700 Receives NMPA Approval in China

ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging capabilities JENA, Germany and SHANGHAI, June 5, 2025 /CNW/ -- ZEISS Medical Technology announced...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress